May 3, 2023 | Medicaid Providers
On January 1, 2023, HHSC will designate one medication as the primary preferred direct-acting antiviral (DAA) drug option for treating Hepatitis C infection. HHSC will designate all other DAA drugs on the Medicaid formulary as non-preferred. All Medicaid clients are...
May 2, 2023 | Medicaid News, Member News
For individuals who are no longer eligible for Medicaid and require HIV care or medications, assistance is available. Individuals may receive HIV care and medications through the Ryan White program. Additional information on AIDS service organizations, case management...
May 1, 2023 | HHSC News, Provider News, Provider Resource
The Affordable Care Act (ACA) requires that Medicaid Providers enroll in state Medicaid programs and then periodically revalidate their Medicaid enrollment at least every five years; however, certain Providers may be required to revalidate more often based on risk...
May 1, 2023 | HHSC News, Provider News, Provider Resource
Texas Medicaid and Healthcare Partnership (TMHP) has identified several National Provider Identifiers (NPI) as inactive in the National Plan and Provider Enumeration System (NPPES) and will be taking immediate disenrollment action, which will result in a payment...
May 1, 2023 | HHSC News, Provider News, Provider Resource
Effective with the end of the federal public health emergency (PHE) on May 11, 2023, the Texas Health and Human Services Commission (HHSC) will end multiple temporary flexibilities related to the COVID-19 pandemic. As a result, infection control supplies procedure...
